首页> 外文期刊>The International journal of drug policy >Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention
【24h】

Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention

机译:在道德和人权方面必须确保在监狱和审前拘留中对阿片类药物依赖进行药物辅助治疗

获取原文
获取原文并翻译 | 示例
       

摘要

Opioid dependence is a complex medical condition affecting neurocognitive and physical functioning. Forced or abrupt opioid withdrawal may cause profound physical and psychological suffering, including nausea, vomiting, diarrhoea, extreme agitation and/or anxiety. Opioid-dependent individuals are especially vulnerable at the time of arrest or initial detention, when they may, as a result of their chemical dependency, be coerced into providing incriminating testimony, or be driven to engage in risky behaviour (such as sharing needles in detention) in order to avoid painful withdrawal symptoms. Upon incarceration, many opioid-dependent prisoners are forced to undergo abrupt opioid withdrawal (both from legally prescribed agonist therapy such as methadone as well as illicit opioids). Physical and psychological symptoms attendant to withdrawal may impair capacity to make informed legal decisions, and cause prisoners to risk HIV and other blood-borne diseases by sharing injection equipment. Although prisonsmust provide at least the standard of care to prisoners that is available in the general population, medication-assisted treatment, endorsed by international health and drug agencies as an integral part of HIV prevention and care strategies for opioid-dependent drug users, is unavailable to most prisoners. Medication-assisted treatment is a well-studied and validated pharmacological therapy for the medical condition known as opioid dependence. The failure to ensure prisoner access to this medical therapy threatens fundamental human rights protections against cruel, inhuman or degrading treatment and rights to health and to life. It also poses serious ethical problems for health care providers, violating basic principles of beneficence and non-maleficence (i.e., do good/do no harm). Governments must take immediate action to ensure access to opioid substitution to prisoners to ensure fulfilment of ethical and human rights obligations.
机译:阿片类药物依赖性是影响神经认知和身体功能的复杂医学疾病。强迫或突然停用阿片类药物可能会造成严重的身心痛苦,包括恶心,呕吐,腹泻,剧烈躁动和/或焦虑。依赖阿片类药物的个体在被捕或初次拘留时特别脆弱,当他们由于其化学依赖性而可能被强迫提供有罪证词或被迫从事危险行为(例如在拘留中共用针头)时)以免出现痛苦的戒断症状。监禁后,许多依赖阿片类药物的囚犯被迫接受突然的阿片类药物戒断(均来自法律规定的激动剂治疗,如美沙酮和非法阿片类药物)。撤药时出现的身体和心理症状可能会削弱做出知情的法律决定的能力,并导致囚犯通过共用注射设备而患上艾滋病毒和其他血液传播疾病。尽管监狱必须至少为普通人群提供囚犯照料的标准,但尚无获得国际卫生和毒品机构认可的药物辅助治疗方法,作为艾滋病毒预防和阿片类药物依赖者护理策略不可或缺的一部分。对大多数囚犯而言。药物辅助治疗是一种针对阿片类药物依赖性的医学状况,经过充分研究和验证的药理疗法。无法确保囚犯获得这种药物疗法,会威胁到基本的人权保护,以免受残忍,不人道或有辱人格的待遇以及健康和生命权。这也给卫生保健提供者带来了严重的道德问题,违反了仁慈和非罪恶的基本原则(即有益/无害)。各国政府必须立即采取行动,以确保囚犯能够获得阿片类药物替代品,以确保履行道德和人权义务。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号